GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annji Pharmaceutical Co Ltd (ROCO:7754) » Definitions » Current Accrued Expense

Annji Pharmaceutical Co (ROCO:7754) Current Accrued Expense : NT$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Annji Pharmaceutical Co Current Accrued Expense?

Annji Pharmaceutical Co's Current Accrued Expense for the quarter that ended in Dec. 2024 was NT$0.00 Mil.

Annji Pharmaceutical Co Current Accrued Expense Historical Data

The historical data trend for Annji Pharmaceutical Co's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Annji Pharmaceutical Co Current Accrued Expense Chart

Annji Pharmaceutical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Current Accrued Expense
- - - -

Annji Pharmaceutical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24
Current Accrued Expense Get a 7-Day Free Trial - - - - -

Annji Pharmaceutical Co Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Annji Pharmaceutical Co Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Annji Pharmaceutical Co's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Annji Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annji Pharmaceutical Co Ltd (ROCO:7754) » Definitions » Current Accrued Expense
Comparable Companies
ROCO:6748 TPE:1762 ROCO:6704 ROCO:4130 ROCO:6892 ROCO:6676 ROCO:1295 ROCO:6846 ROCO:4168 ROCO:6461 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Zhongxiao E. Raod, 16th Floor-6, No. 508, Sector 7, Nangang Distrist, Taipei, TWN, 115011
Website
https://www.ajpharm.com
Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy's disease, or SBMA (Spinal and bulbar muscular atrophy). Its pipeline products include AJ201, AJ302 and AJ303.

Annji Pharmaceutical Co Headlines

No Headlines